| Income Statement | 2025-09-30 | 2025-03-31 | 2024-09-30 | |
|---|---|---|---|---|
| Total revenue | 328,811 | 408,160 | 292,263 | |
| Cost of commissions and other services revenue | 69,101 | 79,412 | 65,733 | |
| Cost of goods soldpharmacy revenue | 192,779 | 162,304 | 129,524 | |
| Marketing and advertising | 61,947 | 92,733 | 63,764 | |
| Selling, general, and administrative | 35,819 | 41,685 | 36,145 | |
| Technical development | 9,911 | 9,967 | 9,074 | |
| Total operating costs and expenses | 369,557 | 386,101 | 304,240 | |
| Loss from operations | -40,746 | 22,059 | -11,977 | |
| Interest expense, net | 11,808 | 20,407 | 23,031 | |
| Change in fair value of warrants | -15,036 | -32,986 | - | |
| Other expense, net | -145 | -37 | -12 | |
| Loss before income tax expense (benefit) | -37,663 | 34,601 | -35,020 | |
| Income tax expense (benefit) | -7,204 | 8,579 | 9,526 | |
| Net loss | -30,459 | 26,022 | -44,546 | |
| Change in cash flow hedge | - | - | -2,785 | |
| Other comprehensive loss | - | - | -2,785 | |
| Senior non-convertible preferred stock accumulated dividends and accretion | 17,482 | 5,787 | - | |
| Comprehensive loss | - | - | -47,331 | |
| Net loss attributable to common shareholders | -47,941 | 20,235 | - | |
| Basic (in dollars per share) | -0.26 | 0.11 | -0.26 | |
| Basic (in shares) | 185,816,000 | 178,156,000 | 170,431,000 | |
| Diluted (in dollars per share) | -0.26 | 0.03 | -0.26 | |
| Diluted (in shares) | 185,816,000 | 186,639,000 | 170,431,000 | |
SelectQuote, Inc. (SLQT)
SelectQuote, Inc. (SLQT)